Pfizer's quarterly financial report on Tuesday comes at a critical moment for the U.S. drugmaker and its CEO, as activist …
Income investors have both good and not-so-good options in the healthcare sector.
Pfizer's high dividend yield and robust pipeline could offer significant returns for patient investors.